Transcatheter pacemaker implantation in a patient with a bioprosthetic tricuspid valve
A 66-year-old white female s/p mitral and tricuspid valve replacement was seen in cardiac consultation and diagnosed with atrial fibrillation and high-degree atrioventricular (AV) block with symptomatic bradycardia, thus pacemaker placement was recommended. For this particular patient, a standard, single-lead implantable pacemaker, while not contraindicated, was not a preferable solution due to the patient’s newly implanted bioprosthetic tricuspid valve and the potential complications transvalvular lead placement may bring [1]. No FDAapproved leadless pacemaker is available in the USA at this time; however, initial safety and feasibility trials have shown comparable results to traditional transvenous leads [2].